Concepedia

Publication | Open Access

Benefit of burosumab in adults with X-linked hypophosphataemia (XLH) is maintained with long-term treatment

DOIFull Paper Access

33

Citations

19

References

2023

Year

Peter Kamenický, Karine Briot, Maria Luisa Brandi, Martine Cohen‐Solal, Rachel Crowley, Richard Keen, S. Kolta, Robin Lachmann, Anne-Lise Lecoq, Stuart H. Ralston,
RMD Open

Abstract

Phase 3: NCT02526160; open-label extension: NCT03920072.

References

YearCitations

Page 1